METFORMIN HYDROCHLORIDE EXTENDED RELEASE (METFORMIN HYDROCHLORIDE)
METFORMIN HYDROCHLORIDE EXTENDED RELEASE (METFORMIN HYDROCHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE; Generic name: METFORMIN HYDROCHLORIDE; Manufacturer: Aphena Pharma Solutions - Tennessee, LLC.
| Brand name | METFORMIN HYDROCHLORIDE EXTENDED RELEASE |
|---|---|
| Generic name | METFORMIN HYDROCHLORIDE |
| Manufacturer | Aphena Pharma Solutions - Tennessee, LLC |
| Used for | Metformin Hydrochloride Extended-Release Tablets, USP is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. |
| Dosage | There is no fixed dosage regimen for the management of hyperglycemia in patients with type 2 diabetes with metformin hydrochloride extended-release tablets or any other pharmacologic agent. Dosage of metformin hydrochloride extended-release tablets must be individualized on the basis of both effectiveness and tolerance, while not exceeding the maximum recommended daily doses. The maximum recommended daily dose of metformin hydrochloride extended-release tablets in adults is 2000 mg. Metformin hy |
| Warnings | WARNING: LACTIC ACIDOSIS Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metforminassociated lactic acidosis was characterized by elevated blood lactate levels (>5 mmol/Liter), anion gap acidosis (without evidence o |
| Active ingredient(s) | METFORMIN HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b843f12-a654-4751-be1f-55e6fce163c9 |